Immunoglobulins promote remyelination in the central nervous system
- PMID: 2301922
- DOI: 10.1002/ana.410270104
Immunoglobulins promote remyelination in the central nervous system
Abstract
Remyelination of central nervous system axons was promoted by systemic injection of serum immunoglobulin G (IgG) from donor mice hyperimmunized with homogenized spinal cord. In SJL/J mice infected with Theiler's virus, primary demyelination and inflammation in the spinal cord were extensive. Following treatment with IgG to spinal cord homogenate, new myelin synthesis as measured by quantitative morphometry increased sixfold. Cells in areas of remyelination that incorporated [3H]thymidine did not express differentiation markers of macrophages, oligodendrocytes, or astrocytes but were identified by electron microscopic autoradiography as progenitor glial cells. These findings raise the possibility that IgG secreted in demyelinating lesions might have the potential to promote myelin repair.
Comment in
-
Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis.Ann Neurol. 1992 Dec;32(6):834-5. doi: 10.1002/ana.410320624. Ann Neurol. 1992. PMID: 1471879 No abstract available.
Similar articles
-
Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells.Lab Invest. 1991 Mar;64(3):358-70. Lab Invest. 1991. PMID: 2002654
-
Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.Microsc Res Tech. 1995 Oct 15;32(3):230-45. doi: 10.1002/jemt.1070320306. Microsc Res Tech. 1995. PMID: 8527857 Review.
-
A recombinant human IgM promotes myelin repair after a single, very low dose.J Neurosci Res. 2007 Apr;85(5):967-76. doi: 10.1002/jnr.21217. J Neurosci Res. 2007. PMID: 17304578
-
Do central nervous system axons remyelinate?Pathol Biol (Paris). 2000 Feb;48(1):70-9. Pathol Biol (Paris). 2000. PMID: 10729914 Review.
-
Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.J Neurosci Res. 1995 Jun 15;41(3):291-6. doi: 10.1002/jnr.490410302. J Neurosci Res. 1995. PMID: 7563222 Review.
Cited by
-
Disease-modifying agents for multiple sclerosis: recent advances and future prospects.Drugs. 2008;68(17):2445-68. doi: 10.2165/0003495-200868170-00004. Drugs. 2008. PMID: 19016573 Review.
-
Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.J Neurosci. 1998 Apr 1;18(7):2498-505. doi: 10.1523/JNEUROSCI.18-07-02498.1998. J Neurosci. 1998. PMID: 9502810 Free PMC article.
-
Multicolor fluorescence in situ hybridization and pulsed field electrophoresis dissect CMT1B gene region.Hum Genet. 1991 Nov;88(1):13-20. doi: 10.1007/BF00204922. Hum Genet. 1991. PMID: 1683644
-
The potential role of B cell-targeted therapies in multiple sclerosis.Drugs. 2010 Dec 24;70(18):2343-56. doi: 10.2165/11585230-000000000-00000. Drugs. 2010. PMID: 21142258 Review.
-
Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):11-4. doi: 10.1136/jnnp.57.suppl.11. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964842 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources